In August 2024, a leading Chinese pharmaceutical packaging material manufacturer launched the world's first fully intelligent aluminum foil production line in Jiaxing, Zhejiang, with a total investment of 1.2 billion CNY. Integrating 5G IoT, digital twin, and AI visual inspection technologies, the line achieves unmanned operation from raw material feeding to final packaging. Key equipment includes German-made nano-coating machines (±0.1μm precision), Swiss laser perforation systems (≤5μm aperture tolerance), and a blockchain traceability platform for real-time monitoring of production batches and quality data.


The production line increases efficiency by 40%, reduces energy consumption by 22%, and delivers an annual output of 35,000 metric tons, meeting 20% of global demand for high-end pharmaceutical foils. Pfizer and Roche have completed factory audits, with initial orders allocated for mRNA vaccine blister lid stock. The World Packaging Organization (WPO) praised the technology for reducing defect rates from 0.3% to 0.005%, setting new GMP compliance benchmarks.


The FDA's 2024 Serialized Packaging Regulation mandates intelligent production. A Boston Consulting Group report predicts the global smart pharmaceutical packaging market will exceed $18 billion by 2027, with China capturing 35% due to industrial chain advantages. The company plans to establish factories in Southeast Asia and Europe within three years to strengthen global supply chain leadership.